Miroslav Penka
About
In The Last Decade
Miroslav Penka
72 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 95
- Global and Planetary Change 789
- Atmospheric Science 497
- Hematology 370
- Nature and Landscape Conservation 337
- Genetics 325
Countries citing papers authored by Miroslav Penka
This map shows the geographic impact of Miroslav Penka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miroslav Penka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miroslav Penka more than expected).
Fields of papers citing papers by Miroslav Penka
This network shows the impact of papers produced by Miroslav Penka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miroslav Penka. The network helps show where Miroslav Penka may publish in the future.
Co-authorship network of co-authors of Miroslav Penka
This figure shows the co-authorship network connecting the top 25 collaborators of Miroslav Penka. A scholar is included among the top collaborators of Miroslav Penka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miroslav Penka. Miroslav Penka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 9 | |
| 6 | [The current role of warfarin]. | 2 |
| 7 | 5 | |
| 8 | 5 | |
| 9 | 9 | |
| 10 | 5 | |
| 11 | [Plasminogen activator system and its clinical significance in patients with a malignant disease]. | 5 |
| 12 | 5 | |
| 13 | Evaluation of HGF and Endostatin in the bone marrow of patients with multiple myeloma and the effect of peripheral blood admixture | 1 |
| 14 | 26 | |
| 15 | 6 | |
| 16 | Interakce antikoagulačních léků s potravinami a potravinovými doplňky | 0 |
| 17 | Evaluation of hepatocyte growth factor and endostatin in thebone marrow of patients with multiple myeloma and the effect ofperipheral blood admixture | 1 |
| 18 | Příprava nemocného s dlouhodobou antikoagulační léčbou v ambulantní praxi k chirurgickému výkonu | 0 |
| 19 | Sind GPIIb/IIIa-Rezeptor-Antagonisten bei Diabetikern sinnvoll? | 0 |
| 20 | Floodplain forest ecosystem. | 43 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.